Traitement coronavirus guide - activities

Coronavirus: The European Union ordered a new antibody therapy

This Wednesday July 28, the European Union announced they have secured a deal for a new experimental coronavirus therapy, Sotrovimab, developed by UK laboratory GSK. A promising monoclonal antibody therapy.

Covid: effectiveness of monoclonal antibodies challenged by variants

As Covid variants keep on spreading across the world, Eli Lilly laboratories has seen their approval removed for marketing bamlanivimab, as a monotherapy, being a therapy based on monoclonal antibodies. Why? Its effectiveness challenged by new coronavirus strains. Keep reading to find out more!

Covid: Colchicine not working in hospitalized sick, Recovery trial found

Is Colchicine not working in Covid sick already at the hospital? This is the conclusion found by the Recovery trial in a study released this Tuesday May 18, explaining the use of this therapy "was not associated with reductions in mortality, duration of hospital stay, or risk of progressing to invasive mechanical ventilation or death". Yet, this was a promising molecule, according to Montreal Heart Institute in a study released in March 2020 explaining Colchicine was said to be effective against Coronavirus, according to primary results from a clinical trial.

Covid: Pfizer to develop two treatments against the virus

Two treatments against Covid are being studied, but have delivered encouraging primary results… This is what Pfizer France director David Lepoittevin announced this Friday April 9, stating that one of them was to be given orally, the other one intravenously. Two medicines that – if trials show effectiveness – could complete the existing arsenal amid the fight against coronavirus.

Covid: casirivimab/imdevimab cocktail, Regeneron’s promising treatment against the virus

This Monday April 12, Roche and Regeneron laboratories have issued results from phase 3 of their clinical trial for a treatment against Covid, a cocktail of casirivimab and imdevimab able to cut the risk of transmitting the virus within populations.

Covid: what we know and still don’t know about the virus, one year on

Where does it come from, how did it contaminate the entire planet in a matter of months, how to get rid of this? The Covid-19 raised many questions and some of them remain answerless. What do we know about the virus that changed our lives in less than a year? Keep reading to find out more.

Covid: catching a cold to fight against coronavirus better?

According to a study led by searchers from the Glasgow university in Scotland, catching a cold is said to help one’s body fight Covid-19 easier.

Covid: France has approved two monoclonal antibody therapies

This Monday March 15, the Agence du Médicament (French Medicines Agency) announced that two monoclonal antibody therapies, namely REGN-COV2 and Eli Lilly laboratory's therapy based on bamlanivimab and etesevimab were now approved in France.

Covid: Eli Lilly antibody therapy said to reduce hospitalization risks, a study finds

As the race for Covid vaccines and therapies is speeding up all over the world, drugmaker Eli Lilly announced this Wednesday March 10 their antibody therapy mixing Bamlanivimab and Etsesevimab is said to reduced by 87% hospitalization and death risk in the event of severe infection. A combined therapy that received emergency use authorization back to late February from the Food & Drug Administration.

Covid: WHO does not recommend hydroxychloroquine as a preventive drug against the disease

This Tuesday March 2, WHO announced in a memo released in the British Medical Journal that Hydroxychloroquine was not recommended as a preventive drug against Covid, relying on six randomized clinical trials, results have shown the inefficiency of the product to fight against severe coronavirus. In addition to those studies, a study carried out by Epi-phare, lead to the same conclusion.

Coronavirus: interferon beta, an effective treatment soon to be used in France?

According to the pharmaceutical company Synairgen, clinical trials about a treatment based on interferon beta – usually used against sclerosis – gave “very significative” outcomes against coronavirus. A treatment that could relieve severe cases with respiratory distress.

Coronavirus: a vaccine will not be enough to stop the pandemic, WHO warns

As the Pfizer and BioNTech laboratories have announced their vaccine was 90% effective, the World Health Organization director greets the rallying to curb the coronavirus epidemic while vouching every country will be able to enjoy this scientific breakthrough. Yet, this Monday November 16, 2020 Tedros Adhanom Ghebreyesus warns a vaccine will not be enough to stop Covid.

Covid-19: Calquence, an effective treatment against cytokine shocks?

Is Claquence an effective treatment to fight against Covid-19? Pharmaceutical group AstraZeneca has announced phase 2 of their clinical trials with this potential treatment to coronavirus “did not meet the primary endpoint”. A clinical trial which point was to try and assess its effect against cytokine shocks, this violent inflammatory response from the immune system, combined with Covid-19 infection.

Coronavirus: some steroids effective against severe Covid-19, three new studies say

Are some steroids effective against severe Covid-19? This is the conclusion three studies found published in the Journal of the American Medical Association. Their effectiveness led the WHO to authorize their use for cases concerned.

Coronavirus: “Positive results” for the remdesivir/diltiazem treatment the Inserm says

Searchers from the French National Institute for Health and Medical Research (Inserm) in Lyon showed that mixing two medicines, remdesivir and diltiazem, gave “positive results” for a pre-clinical phase. A new step for the discovery of an effective treatment against coronavirus.

Coronavirus: the European Union allows putting Remdesivir on the market

Remdesivir is at the heart of research against coronavirus and has been adopted in the United-States in early May. The European Union is now validating the authorization to put the treatment on the market.

Coronavirus: the lopinavir/ritonavir cocktail ineffective, the Recovery trail says

Is the lopinavir/ritonavir blend to fight against coronavirus ineffective? This is what several leaders of the Recovery trial say.

Coronavirus: WHO urges promising steroid Dexamethasone production to boom

Can dexamethasone be a cure to coronavirus? The clinical trial ran by British searchers seems promising, so much that the World Health Organization hailed the results the British scientists have found and urges to boom production.

Coronavirus: dexamethasone, a steroid that can reduce death by up to one third

According to a British clinical trial, a drug belonging to steroids, is said to reduce Covid-19 sick death rate by up to one third. An encouraging study as no treatment is known yet to fight against the novel coronavirus.

Recovery: hydroxychloroquine useless, the first results of the clinical trial say

Is hydroxychloroquine once and for all useless against coronavirus? This is what seems to say the first results of the British Recovery clinical trial expected by the scientific community. The first conclusions incited the scientific authorities to stop enrolling patients for this branch of the study.